December 3-4 | Boston MA

From Rhetoric... To Results.

The Data; the Strategies; & the Evidence Behind  
Better Outcomes, Reduced Risk & Sustainable Growth

The Women's Health Infrastructure Report 2026

Help us uncover how healthcare leaders are funding, delivering, reimbursing and scaling women's health across the United States.
5 Questions • ✅ 60 Seconds • ✅ Published September 2026

From Debate... To Data. 

Join global biopharma innovators, health system executives, commercial insurance leaders, and clinical pioneers at the definitive cross-functional forum.

Moving past advocacy, we deliver the hard market data, regulatory pathways, and reimbursement strategies required to scale women's health therapeutics and transform patient care.

Organizations Joining WoHX

The Regulatory Catalyst: 
The FDA to Keynote

The paradigm has shifted. 

Federal mandates now dictate absolute sex-specific data diversity in clinical cohorts. 

Join the FDA on the main stage this December to discover their role in strengthening women's health through regulatory science and innovation.

The Multi-Billion Dollar Opportunity Hidden in the Historical Gap

Women drive 80% of all healthcare decisions in the United States, yet systemic failings in preventative care leave immense clinical and commercial potential completely untapped.

Women’s HealthX is the exclusive intersection where the entire healthcare ecosystem aligns to solve this market failure.  

We do not just analyze the gap—we deliver the cross-functional frameworks required to fund it, cover it, prescribe it, and scale it. 

Industry Leaders on Stage

SEE THEM ALL

The WoHX Ecosystem

image

Manage Total Cost of Care & Corporate Risk

Discover next-generation preventative care models and data-driven remote monitoring platforms designed to proactively mitigate high-cost catastrophic maternity claims and optimize employer-sponsored benefit plans.

+
image

Protect Downstream Revenue & Patient Retention

Learn how top-tier academic medical centers are integrating specialized women's health strategies to capture the primary healthcare decision-makers, optimize reimbursement models, and secure long-term patient loyalty.

+
image

Accelerate Market Access & Commercial Viability

Gain concrete regulatory strategies to navigate FDA approvals for sex-specific therapeutics, leverage real-world evidence (RWE), and secure critical insurance formulary placement.

+
image

Mitigating Corporate Healthcare Spend & Eliminate Female Talent Attrition

The silent financial drain on self-insured corporate portfolios isn't general healthcare—it is unmanaged female lifecycle conditions. Benchmark directly with Fortune 500 HR leaders to design specialized benefit strategies that deliver realized, long-term ROI.

+
image

Transition Sex-Specific Data from Bench to Bedside 

Access the latest clinical research on menopause, auto-immune conditions, and cardiovascular health to improve patient outcomes, while exploring operational efficiencies that actively reduce clinical burnout.

image

Secure Capital & Scale Institutional Adoption 

Pitched directly to the ultimate corporate buyers, learn the exact clinical validation and evidence requirements needed to pass hospital IT vetting and secure enterprise-level procurement contracts.